AU2020278566A1 - Inhibitors of fibroblast growth factor receptor kinases - Google Patents

Inhibitors of fibroblast growth factor receptor kinases Download PDF

Info

Publication number
AU2020278566A1
AU2020278566A1 AU2020278566A AU2020278566A AU2020278566A1 AU 2020278566 A1 AU2020278566 A1 AU 2020278566A1 AU 2020278566 A AU2020278566 A AU 2020278566A AU 2020278566 A AU2020278566 A AU 2020278566A AU 2020278566 A1 AU2020278566 A1 AU 2020278566A1
Authority
AU
Australia
Prior art keywords
optionally substituted
pharmaceutically acceptable
compound
solvate
acceptable salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2020278566A
Other languages
English (en)
Inventor
Stephen W. Kaldor
John Tyhonas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kinnate Biopharma Inc
Original Assignee
Kinnate Biopharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kinnate Biopharma Inc filed Critical Kinnate Biopharma Inc
Publication of AU2020278566A1 publication Critical patent/AU2020278566A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AU2020278566A 2019-05-17 2020-05-14 Inhibitors of fibroblast growth factor receptor kinases Abandoned AU2020278566A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201962849534P 2019-05-17 2019-05-17
US62/849,534 2019-05-17
US201962907491P 2019-09-27 2019-09-27
US62/907,491 2019-09-27
PCT/US2020/032939 WO2020236524A1 (en) 2019-05-17 2020-05-14 Inhibitors of fibroblast growth factor receptor kinases

Publications (1)

Publication Number Publication Date
AU2020278566A1 true AU2020278566A1 (en) 2021-12-23

Family

ID=73458745

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2020278566A Abandoned AU2020278566A1 (en) 2019-05-17 2020-05-14 Inhibitors of fibroblast growth factor receptor kinases

Country Status (7)

Country Link
US (1) US20230174535A1 (https=)
EP (1) EP3969442A4 (https=)
JP (1) JP2022533939A (https=)
CN (1) CN114127051A (https=)
AU (1) AU2020278566A1 (https=)
CA (1) CA3139161A1 (https=)
WO (1) WO2020236524A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12441707B2 (en) 2019-12-30 2025-10-14 Tyra Biosciences, Inc. Indazole compounds
US11345681B1 (en) * 2020-06-05 2022-05-31 Kinnate Biopharma Inc. Inhibitors of fibroblast growth factor receptor kinases
CN116096707A (zh) * 2020-06-05 2023-05-09 金耐特生物制药公司 成纤维细胞生长因子受体激酶的抑制剂
KR20240119095A (ko) * 2021-12-08 2024-08-06 킨네이트 바이오파마 인크. Fgfr 저해제의 고체 상태 형태
WO2023107870A1 (en) * 2021-12-08 2023-06-15 Kinnate Biopharma Inc. Inhibitors of fibroblast growth factor receptor kinases
CN120344533A (zh) * 2022-11-22 2025-07-18 海思科医药集团股份有限公司 一种嘧啶衍生物及其在医药上的应用
AU2024301095A1 (en) * 2023-07-26 2026-03-12 Khora Spv 1, Llc Treatment of cancer with a cdk inhibitor

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2168968B1 (en) * 2004-04-02 2017-08-23 OSI Pharmaceuticals, LLC 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors
GB0428082D0 (en) * 2004-12-22 2005-01-26 Welcome Trust The Ltd Therapeutic compounds
US7723336B2 (en) * 2005-09-22 2010-05-25 Bristol-Myers Squibb Company Fused heterocyclic compounds useful as kinase modulators
US20070078136A1 (en) * 2005-09-22 2007-04-05 Bristol-Myers Squibb Company Fused heterocyclic compounds useful as kinase modulators
WO2007064931A2 (en) * 2005-12-02 2007-06-07 Bayer Healthcare Llc Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
MY171055A (en) * 2012-01-19 2019-09-23 Taiho Pharmaceutical Co Ltd 3,5-disubstituted alkynylbenzene compound and salt thereof
GB201503590D0 (en) * 2015-03-03 2015-04-15 Davis Adrian Topical formulation
PT3279202T (pt) * 2015-03-31 2020-08-31 Taiho Pharmaceutical Co Ltd Cristal de composto de alquinilo de benzeno 3,5-dissubstituído
US11221750B2 (en) * 2016-02-12 2022-01-11 Purdue Research Foundation Manipulating 3D virtual objects using hand-held controllers
CN107698593A (zh) * 2016-08-09 2018-02-16 南京天印健华医药科技有限公司 作为fgfr抑制剂的杂环化合物
US10685111B2 (en) * 2016-10-31 2020-06-16 Crowdstrike, Inc. File-modifying malware detection
US11130761B2 (en) * 2016-12-29 2021-09-28 Cspc Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. Substituted pyrrolo[2,1-f][1,2,4]triazines as FGFR inhibitors

Also Published As

Publication number Publication date
WO2020236524A1 (en) 2020-11-26
EP3969442A4 (en) 2023-08-02
EP3969442A1 (en) 2022-03-23
CN114127051A (zh) 2022-03-01
US20230174535A1 (en) 2023-06-08
JP2022533939A (ja) 2022-07-27
CA3139161A1 (en) 2020-11-26

Similar Documents

Publication Publication Date Title
AU2020278566A1 (en) Inhibitors of fibroblast growth factor receptor kinases
US11667634B2 (en) Inhibitors of RAF kinases
WO2024178313A1 (en) Kras modulators
CN113874381A (zh) Raf激酶的抑制剂
US11814384B2 (en) Inhibtors of Raf kinases
WO2023224998A1 (en) Inhibitors of parg
EP4161657A1 (en) Inhibitors of fibroblast growth factor receptor kinases
US11780862B2 (en) Inhibitors of MEK kinase
CN119403803A (zh) Parg抑制剂
TW200813051A (en) Substituted azaspiro derivatives
WO2023107870A1 (en) Inhibitors of fibroblast growth factor receptor kinases
CN116438179B (zh) 作为ret激酶抑制剂的吡唑衍生物
WO2023070053A1 (en) Inhibitors of raf kinases
WO2022066580A1 (en) Raf degrading compounds
HK40064672A (en) Inhibitors of fibroblast growth factor receptor kinases
JP2022527279A (ja) キノリン誘導体及び癌の治療のためのその使用
JP6337092B2 (ja) 三環式トリアゾール系化合物
WO2025032214A1 (en) Indazole compounds and azaindazole compounds as inhibitors of raf kinases
WO2025054260A1 (en) Inhibitors of mek kinase
WO2026060099A1 (en) Selective pi3k inhibitors
HK40063842A (en) Inhibitors of raf kinases
HK1153477A (en) Bridged, bicyclic heterocyclic or spiro bicyclic heterocyclic derivatives of pyrazolo[1,5-a]pyrimidines, methods for preparation and uses thereof

Legal Events

Date Code Title Description
MK1 Application lapsed section 142(2)(a) - no request for examination in relevant period